ISRCTN82694463已完成不适用
A phase III study of primary chemotherapy in T2 (G3), T3 and T4a; N0 or NX; M0 transitional cell carcinoma (TCC) of the bladder
Medical Research Council (MRC) (UK)0 个研究点目标入组 975 人开始时间: 2001年3月13日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 975
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Histologically proven TCC of the bladder with biopsy-proven muscle invasion
- •2. Tumours considered curable (less than or equal to 7 cm)
- •3. GFK =50 ml/min (Cockcroft)
- •4. White blood count (WBC) >3.5 x 10^9/L and platelet count >100 x 10^9/
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
2 期
Phase II study of combination chemotherapy in treating pediatric patients with newly diagnosed intracranial germinomaJPRN-UMIN000002397Japanese Pediatric Brain Tumor Consortium50
已完成
不适用
Phase I/II study of first line chemotherapy with TS-1 in elderly patients with advanced non-small cell lung canceron-small cell lung cancerJPRN-UMIN000002994Kagawa TGO Study Group45
已完成
2 期
Phase II study of Chemotherapy for Advanced or Recurrent ThymomaThymoma (excluding thymic carcinoma)JPRN-C000000350Japanese Association for Research on the Thymus50
已完成
2 期
Phase II study of intensive chemotherapy in treating pediatric patients with newly diagnosed cranial nongerminomaous germ cell tumorJPRN-UMIN000002398Japanese Pediatric Brain Tumor Consortiun20
已完成
不适用
Phase II study of second-line chemotherapy using modified FOLFOX6 in patients with advanced/ recurrent colorectal cancer (OGSG 0505)Patients with unresectable or metastatic colon cancer registant to fluorouracil treatmentJPRN-UMIN000000841OGSG50